Festo is a leading supplier of automation solutions to the global markets serving over 180 countries.
With over 40 years of innovation in the United States and over 80 years globally, Festo is the manufacturer of choice for control valves, I/O and fieldbus control. Our broad range of products and services span the full needs of the automation industry including cabinet design and energy reduction solutions. Festo also offers a range of process valves, actuators, sensors, air preparation, and packaging components.
Our dedication to the advancement of automation extends beyond technology to the education of current and future automation and robotic designers with simulation tools, teaching programs and on-site services.
From a component to a complete system consisting of drives, sensors, valves, a connector system and air preparation – Festo offers products, special and complete solutions for all sectors and production operations within the pharmaceutical and biotech industry.
1377 Motor Parkway, Suite 310
Islandia, NY 11749
Filtration and separation technologies are the core of water treatment processes, and in many cases, they can be critical process bottlenecks.
Small batches and multiple products in the same plant — these are the market demands to which more and more manufacturers need to adjust. The answer is based on the "Lego principle."
The concept for the production of infusion solutions for the new three-chamber bags is standard automation.
Productivity is more reliable when equipment can be monitored to detect incipient failures and take corrective action before the plant goes down.
This white paper offers guidance on the challenges in the individual value creation phases, support tools, how to become more productive with networked tools, and tips about which functions can be used.
The short tips in this white paper are intended as a guide to selecting tools which will help users to save valuable time in the eight-phase model of the value creation process.
Proportional valve technology in process automation offers a great a deal of flexibility and produces high-quality control results.
Today’s biotech and pharmaceutical production facilities must drive faster times to market and greater profitability by boosting production yields and accelerating commercialization.
Lab automation equipment makers should keep outsourcing strategies flexible as "make‐versus‐buy" decision drivers change. This article offers four factors to help in outsourcing decision making.
In many process automation applications, the pressure and flow of gases are controlled. Explosion protection requirements mean that an inert atmosphere is often created and maintained in reactors and process tanks in a plant. This is usually done with nitrogen and in some cases also with argon. Other applications include the transfer of materials between process tanks and filling, using inert gas, air, sterile air and carbon dioxide.
Merck Serono, the pharmaceutical arm of Merck KGaA, is investing 350 million euros in its new plant and creating 200 new jobs for biologists, engineers, technicians and laboratory staff. Drugs based on complex molecules that cannot be synthesised chemically are created in a biotechnological process on four production lines with a bioreactor capacity of 140,000 litres. This includes the development of the cell bank, the production of proteins in the bioreactors and filtration and purification for the purest protein concentrations.
The global market for valves and valve terminals today is so large that it is almost impossible to maintain an overview. Often, price seems the only buying criterion. But it pays to look more closely, particularly with regard to higher productivity and process reliability.
Efficient use of compressed air is an area where many manufacturing operations can make considerable savings.
The driving force behind progress in Industrial automation in the last 10 years has without doubt been the networking of automation products via bus systems.